For 15 % of cases.

There is no defined role for chemotherapy in patients with lung cancer were 25 years ago the data were starting to come together for small cell lung cancer. For 15 % of cases, but there was little reliable evidence for its role in non-small cell disease.

But how clinical trials in the 1990s began to production of data, the researchers were a bit more confident that chemotherapy could prolong survival.Of types of cancer We stay tensioned to be partnering with Celsion, and look forward to the beginning of the clinical trial as soon as. ‘.. ‘ The combination of the Philips ‘ MR-HIFU system, a high-precision, heat -based therapy and ThermoDox, a thermal Triggered oncolytic agent that have great potential, it gives us the chance, non-invasive thermally be combined treatment the local local supply high concentrations of on potent anti-cancer drugs straight well in a target region uncharacterized ‘, Falko coaches, VP and General manager, MRI Therapy said, to Philips Healthcare has.

Celsion is the leading oncology company specializing in the history and commercialization of innovative cancer medicines including tumors targeting treatment with focus heating energy in combination with heat activated liposomal active ingredient technology. Celsion maintains research, license, or commercialization agreements with industry leaders institutions including the NIH, Duke University Medical Center, University of Hong Kong, and noninvasive UCLA Department of Medicine, who Kyungpook National University Hospital, China Cancer Hospital and at Oxford University..